diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes, Obesity and Metabolism | Added Jul 26, 2021
Comparing second-line therapy options combined with metformin for patients with type 2 diabetes.
This study explored the effects of different second-line therapies combined with metformin (Glucophage) in patients with type 2 diabetes (T2D). The data showed that metformin combinations with a sulfonylurea (SU) had the lowest weight loss, the smallest effect of lowering blood glucose, and an overall, reduced health status.
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes, Obesity and Metabolism | Added Jul 23, 2021
Saxagliptin as an add-on treatment in type 2 diabetes
The authors aimed to determine the safety and efficacy of saxagliptin (Onglyza) as an add-on treatment in patients with type 2 diabetes already receiving treatment with dapagliflozin (Farxiga) and metformin (Glucophage).
The authors concluded that using saxagliptin as an add-on treatment for 52 weeks resulted in improvements in blood sugar control without an increase in body weight or an increased risk of hypoglycaemia (deficiency of sugar in the blood).
diabetes mellitus | Research | 10 pages | source: Diabetes Research and Clinical Practice | Added Jul 21, 2021
Can eye imaging be used to screen for diabetic retinopathy remotely?
This study looked at remote screening for diabetic retinopathy (DR; eye disease) in a Japanese population. This study showed that remote screening for DR is an effective way of identifying patients who need ophthalmic intervention.
diabetes mellitus | Research | Treatment | 10 pages | source: European journal of clinical pharmacology | Added Jul 19, 2021
Can melatonin help relieve pain in patients with painful diabetic nerve disease?
This study aimed to explore the effects of melatonin in addition to pregabalin (Lyrica) for the management of painful diabetic neuropathy (PDN). The authors concluded that melatonin added to pregabalin may help in reducing pain related to PDN in patients with type 2 diabetes (T2D).
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes Care | Added Jul 17, 2021
Evaluating the outcomes of cotadutide treatment for patients with type 2 diabetes
This study evaluated the outcomes of cotadutide (MEDI0382) treatment in patients with type 2 diabetes (T2D) and obesity. This study concluded that cotadutide treatment improved glycemic (blood sugar) control and weight loss in these patients.
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes Research and Clinical Practice | Added Jul 15, 2021
Are all glucagon-like peptide-1 receptor agonists equally safe and effective in patients with type 2 diabetes?
This study looked at 8 glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes (T2D). They found that all 8 were more effective than placebo and there were no significant differences in safety.
diabetes mellitus | Research | Lifestyle | 10 pages | source: PLOS ONE | Added Jul 13, 2021
Can exercise improve nerve health of the heart in patients with diabetes?
This review looked at whether exercise can improve heart rate variability (HRV) for patients with type 2 diabetes (T2D). It found that exercise improved HRV, which indicates better nerve health of the heart.
diabetes mellitus | Medivizor | source: Medivizor | Added Jul 11, 2021
Being a Pancreas: Life with Type 1 Diabetes
The time, energy and intellectual capacity of being a pancreas is daunting. “I am often the only person around who needs to do complicated mathematical equations before eating anything, before going anywhere, before mowing my lawn, shoveling snow, taking a walk, or before going to sleep at night. Diabetes isdiabetes mellitus | Research | 5 pages | source: Diabetologia | Added Jul 08, 2021
What can Roux-en-Y gastric bypass do for microvascular complications in type 2 diabetes?
This study examined the effect of Roux-en-Y gastric bypass (stomach shrinking) surgery on microvascular (small blood vessel) complications of type 2 diabetes.
diabetes mellitus | Medivizor | source: Medivizor | Added Jul 06, 2021
Myth Busting Diabetes
Stigma and Myths Stigma and myths go hand in hand. Myths feed the fear and misunderstanding that people use to stigmatize others and blame victims. Branding people by saying that they "caused their condition" is unproductive and unfair. This problem is happening with Type 1 and Type 2 diabetes. Here
